technetium-tc-99m-medronate and Cardiomyopathy--Hypertrophic

technetium-tc-99m-medronate has been researched along with Cardiomyopathy--Hypertrophic* in 2 studies

Reviews

1 review(s) available for technetium-tc-99m-medronate and Cardiomyopathy--Hypertrophic

ArticleYear
Can Nuclear Imaging Techniques Predict Patient Outcome and Guide Medical Management in Hereditary Transthyretin Cardiac Amyloidosis?
    Current cardiology reports, 2018, 03-24, Volume: 20, Issue:5

    Nuclear imaging recently gained a key role in the diagnosis and prognostic assessment of transthyretin (TTR)-related cardiac amyloidosis. This review aims at summarizing the state-of-the art regarding the implementation of nuclear imaging in the management of hereditary mutated TTR-cardiac amyloidosis (mTTR-CA).. Although cardiac uptake of bone tracers is acknowledged as a specific marker of TTR amyloid cardiac burden, recent studies validated the implementation of bone scan in the flow chart for non-invasive diagnosis and follow-up of CA in multicenter trials. Simultaneously, cardiac denervation evidenced by MIBG scintigraphy proved to be a strong and independent prognostic marker of poor outcome in mTTR-CA. By its unique ability to assess both amyloid burden and cardiac denervation, nuclear imaging may prove useful as part of multimodality imaging tools to trigger treatment initiation and monitoring in patients with mTTR-CA.

    Topics: Amyloid; Amyloid Neuropathies, Familial; Cardiomyopathy, Hypertrophic; Humans; Multimodal Imaging; Prealbumin; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate

2018

Other Studies

1 other study(ies) available for technetium-tc-99m-medronate and Cardiomyopathy--Hypertrophic

ArticleYear
Vagal enhancement linking abnormal blood pressure response and subendocardial ischemia in hypertrophic cardiomyopathy.
    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2014, Volume: 19, Issue:1

    An abnormal blood pressure response to exercise has been reported to be associated with left ventricular subendocardial ischemia in patients with hypertrophic cardiomyopathy (HCM), but the underlying mechanism remains unclear. We report a case of HCM with an abnormal blood pressure response and subendocardial ischemia, in which the analysis of heart rate variability revealed exercise-induced vagal enhancement. The present case highlights the possible mechanism linking abnormal blood pressure response and left ventricular subendocardial ischemia in patients with HCM.

    Topics: Aged; Blood Pressure; Cardiomyopathy, Hypertrophic; Diagnosis, Differential; Exercise Test; Female; Heart Rate; Heart Ventricles; Humans; Myocardial Ischemia; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon; Vagus Nerve

2014